Your search returned 5 results.

Results
	1.	CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response. [electronic resource] by Kuhn, Nicholas F Purdon, Terence J van Leeuwen, Dayenne G Lopez, Andrea V Curran, Kevin J Daniyan, Anthony F Brentjens, Renier J Producer: 20191223 In: Cancer cell vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression. [electronic resource] by Curran, Kevin J Seinstra, Beatrijs A Nikhamin, Yan Yeh, Raymond Usachenko, Yelena van Leeuwen, Dayenne G Purdon, Terence Pegram, Hollie J Brentjens, Renier J Producer: 20160405 In: Molecular therapy : the journal of the American Society of Gene Therapy vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System. [electronic resource] by Avanzi, Mauro P Yeku, Oladapo Li, Xinghuo Wijewarnasuriya, Dinali P van Leeuwen, Dayenne G Cheung, Kenneth Park, Hyebin Purdon, Terence J Daniyan, Anthony F Spitzer, Matthew H Brentjens, Renier J Producer: 20191202 In: Cell reports vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL. [electronic resource] by Geyer, Mark B Rivière, Isabelle Sénéchal, Brigitte Wang, Xiuyan Wang, Yongzeng Purdon, Terence J Hsu, Meier Devlin, Sean M Palomba, M Lia Halton, Elizabeth Bernal, Yvette van Leeuwen, Dayenne G Sadelain, Michel Park, Jae H Brentjens, Renier J Producer: 20200924 In: JCI insight vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. [electronic resource] by Rafiq, Sarwish Yeku, Oladapo O Jackson, Hollie J Purdon, Terence J van Leeuwen, Dayenne G Drakes, Dylan J Song, Mei Miele, Matthew M Li, Zhuoning Wang, Pei Yan, Su Xiang, Jingyi Ma, Xiaojing Seshan, Venkatraman E Hendrickson, Ronald C Liu, Cheng Brentjens, Renier J Producer: 20190429 In: Nature biotechnology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)